Gene Therapy - Table of Contents alert Volume 20 Issue 2

TABLE OF CONTENTS Volume 20, Issue 2 (February 2013) In this issue News and Commentary Review Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Experimental & Molecular Medicine (EMM) Now Live - co-published with the Korean Society for Biochemistry and Molecular Biology (KSBMB), EMM seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Read content and make sure you receive the latest by registering to receive the Table of Contents e-alert for EMM Learn more about EMM   News and Commentary Top Cathelicidin gene therapy: a new therapeutic option in ulcerative colitis and beyond? A Ahluwalia and A S Tarnawski Gene Ther 2013 20: 119-120; advance online publication, March 29, 2012; 10.1038/gt.2012.23 Full Text Review Top Zinc-finger nucleases: looking toward translation N J Palpant and D M Dudzinski Gene Ther 2013 20: 121-127; advance online publication, February 9, 2012; 10.1038/gt.2012.2 Abstract | Full Text Original Articles Top Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening H Wang, T-H Jia, N Zacharias, W Gong, H-X Du, P H Wooley and S-Y Yang Gene Ther 2013 20: 128-135; advance online publication, February 9, 2012; 10.1038/gt.2012.1 Abstract | Full Text Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK B R Anderson, K Karikó and D Weissman Gene Ther 2013 20: 136-142; advance online publication, February 2, 2012; 10.1038/gt.2012.5 Abstract | Full Text Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma M Gutova, G M Shackleford, V Khankaldyyan, K A Herrmann, X-H Shi, K Mittelholtz, Y Abramyants, M S Blanchard, S U Kim, A J Annala, J Najbauer, T W Synold, M D'Apuzzo, M E Barish, R A Moats and K S Aboody Gene Ther 2013 20: 143-150; advance online publication, March 8, 2012; 10.1038/gt.2012.12 Abstract | Full Text Electroporation-mediated gene transfer directly to the swine heart B Hargrave, H Downey, R Strange, Jr, L Murray, C Cinnamond, C Lundberg, A Israel, Y-J Chen, W Marshall, Jr and R Heller Gene Ther 2013 20: 151-157; advance online publication, March 29, 2012; 10.1038/gt.2012.15 Abstract | Full Text Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and ‘in vivo’ tracing with AAV vector serotype 6 J R Ferreira, M L Hirsch, L Zhang, Y Park, R J Samulski, W-S Hu and C-C Ko Gene Ther 2013 20: 158-168; advance online publication, March 8, 2012; 10.1038/gt.2012.16 Abstract | Full Text A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay A L Aloia, L Duffy, V Pak, K E Lee, S Sanchez-Martinez, D Derse, G Heidecker, K Cornetta and A Rein Gene Ther 2013 20: 169-176; advance online publication, March 8, 2012; 10.1038/gt.2012.18 Abstract | Full Text T cells redirected by a CD3ζ chimeric antigen receptor can establish self-antigen-specific tumour protection in the long term M Chmielewski, G Rappl, A A Hombach and H Abken Gene Ther 2013 20: 177-186; advance online publication, March 1, 2012; 10.1038/gt.2012.21 Abstract | Full Text Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp−/− mice E K K Tai, W K K Wu, X J Wang, H P S Wong, L Yu, Z J Li, C W Lee, C C M Wong, J Yu, J J Y Sung, R L Gallo and C H Cho Gene Ther 2013 20: 187-193; advance online publication, March 1, 2012; 10.1038/gt.2012.22 Abstract | Full Text Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception T Oguchi, Y Funahashi, H Yokoyama, O Nishizawa, W F Goins, J R Goss, J C Glorioso and N Yoshimura Gene Ther 2013 20: 194-200; advance online publication, March 8, 2012; 10.1038/gt.2012.24 Abstract | Full Text Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells R van Rensburg, I Beyer, X-Y Yao, H Wang, O Denisenko, Z-Y Li, D W Russell, D G Miller, P Gregory, M Holmes, K Bomsztyk and A Lieber Gene Ther 2013 20: 201-214; advance online publication, March 22, 2012; 10.1038/gt.2012.25 Abstract | Full Text Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEK Open C L Skelly, Q He, L Spiguel, S McCormick and R Weichselbaum Gene Ther 2013 20: 215-224; advance online publication, March 15, 2012; 10.1038/gt.2012.26 Abstract | Full Text Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery S Chen, M Shimoda, J Chen and P A Grayburn Gene Ther 2013 20: 225-233; advance online publication, November 15, 2012; 10.1038/gt.2012.89 Abstract | Full Text Corrigenda Top Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery S Chen, M Shimoda, J Chen and P A Grayburn Gene Ther 2013 20: 234; advance online publication, December 6, 2012; 10.1038/gt.2012.94 Full Text Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells T Aoki, H Kataoka, M Nishimura, R Ishibashi, R Morishita and S Miyamoto Gene Ther 2013 20: 235; 10.1038/gt.2012.95 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.